Seeing Is Believing
Healthcare - Sector
Clovis Oncology's activity chart (see below) currently has 163 price targets and 125 ratings on display.
Analysts average stock forecasts to be materialized ratio is 56.35% with an average time for these price targets to be met of 81.22 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 14-Jun-2022. First documented stock forecast 03-Jun-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-Jun-2022
4 years 4 months 5 days ago
(14-Jun-2022)
0/13 (0%)
$2.53 (172.11%)
Hold Since 30-Oct-2018
$4.75
$4.66 (5177.78%)
$5.75
4 years 11 months 16 days ago
(03-Nov-2021)
8/10 (80%)
$0.06 (1.28%)
66
Sell Since 20-May-2020
$3
$2.91 (3233.33%)
5 years 11 months 13 days ago
(06-Nov-2020)
3/5 (60%)
$-1.26 (-29.58%)
151
Buy Since 09-May-2018
$16
$15.91 (17677.78%)
$17
6 years 2 months 12 days ago
(07-Aug-2020)
4/11 (36.36%)
$10.58 (195.20%)
88
Sell Since 08-Oct-2019
6 years 5 months 13 days ago
(06-May-2020)
0/2 (0%)
$25.85 (43.70%)
What is CLVS (Clovis Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on CLVS (Clovis Oncology)?
Which analyst has the most public recommendations on CLVS (Clovis Oncology)?
Which analyst is the currently most bullish on CLVS (Clovis Oncology)?
Which analyst is the currently most reserved on CLVS (Clovis Oncology)?